Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Ανάλυση Κόστους-Οφέλους (ΑΚΟ)× | Έτος Ζωής Προσαρμοσμένο στην Ποιότητα (QALY)× | |
|---|---|---|
| Πεδίο | Οικονομικά της Υγείας | Οικονομικά της Υγείας |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 1970s | 1985 |
| Δημιουργός≠ | Boardman, Greenberg, and colleagues (welfare economics) | Alan Williams (Health Economics Research Centre, Oxford University) |
| Τύπος | Method | Method |
| Θεμελιώδης πηγή≠ | Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press. link ↗ | Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley. link ↗ |
| Εναλλακτικές ονομασίες≠ | CBA, economic appraisal, benefit-cost ratio | QALY, health utility measure |
| Συναφείς | 5 | 5 |
| Σύνοψη≠ | Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types. | A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|